Alchemy has secured a multimillion-dollar investment agreement with Ting Li Development to expand its low-GI food innovation into Greater China, emphasizing the growing demand for healthier dietary options.
Information on the Target
Alchemy is a Singapore-based food technology start-up that focuses on developing low glycaemic index (Low-GI) foods aimed at diabetics, high-risk groups, and health-conscious consumers. Established with the principle of prioritizing taste and texture, Alchemy has made a name for itself over five years of extensive research and development, successfully earning recognition from hospitals and healthcare professionals as well as partnerships with restaurants and food manufacturers serving the general public.
The company has recently made significant progress in expanding its market reach and products. Alchemy has pioneered a unique offering that integrates nutritional value without compromising on flavor, allowing it to enter diverse partnerships and gain visibility in both healthcare and food service sectors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Singapore
Singapore’s food industry is witnessing a substantial rise in demand for healthier food options, driven by growing awareness of diabetes and chronic health conditions among its population. The market is characterized by a shift towards products that offer both health bene
Similar Deals
Plantas Medicinales y Complementos Alimenticios, S.A. → NutriBiotic
2025
ITC Limited → Sproutlife Foods Private Limited
2025
Ting Li Development
invested in
Alchemy
in 2023
in a Strategic Partnership deal
Disclosed details
Transaction Size: $6M